3Carter CL, Allen C, Henson DE. Relation of tumor size,lymph node status, and survival in 24 740 breast cancer cases[J]. Cancer, 1989,63(1):181-187.
4Pantel K, Felber E, Schlimok G. Detection and characterization of residual disease in breast cancer [J]. J Hematother, 1994,3(4) :315-322.
5Mansi JL, Gogas H, Bliss JM, et al. Outcome of primary breast cancer patients with micrometastases: a long-term follow-up study [J]. Lancet, 1999,354(9174): 197-202.
6Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage Ⅰ ,Ⅱ, or Ⅲ breast cancer [J]. N Engl J Med, 2000,342(8):525-533.
7Gebauer G, Fehm T, Merkle E, et al. Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up [J]. J Clin Oncol, 2001,19 (16): 3669-3674.
8Kraeft SK, Sutherland R, Gravelin L, et al. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system [J]. Clin Cancer Res, 2000,6(2):434-442.
9Witzig TE, Bossy B, Kimlinger T, et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy [J]. Clin Cancer Res, 2002,8(5): 1085-1091.
10Watson MA, Fleming TP. Mammaglobin a mammary-specific member of the uterglobin gene family is overexpressed in human breast cancer[ J ].Cancer Res, 1996,56:860.
